Navigation Links
POET to Outline Cellulosic Ethanol's Present, Future at Brazil's Ethanol Summit 2009
Date:5/26/2009

Rapid advancements in producing cellulosic ethanol and the fuel's promise for the future will be highlighted by POET next week at Ethanol Summit 2009 in Sao Paulo, Brazil.

Sioux Falls, S.D. (Vocus) May 26, 2009-- Rapid advancements in producing cellulosic ethanol and the fuel's promise for the future will be highlighted by POET next week at Ethanol Summit 2009 in Sao Paulo, Brazil.

POET Director of Corporate Affairs Doug Berven will be one of four panelists in a plenary session titled "Second Generation Ethanol: Realities and Possibilities" from 2-4 p.m. Monday, June 1 at the Sheraton World Trade Center in Sao Paulo. Joining Berven will be Novozymes CEO Steen Riisgaard, CanaVialis-Monsanto President Ricardo Madureira and BP Biofuels General Manager for Technology Ian Dobson.

POET will produce cellulosic ethanol from corn cobs in 2011 through Project LIBERTY, a $200 million plant to be built in Emmetsburg, Iowa. POET's pilot plant in Scotland, S.D. is already using that process to produce ethanol at a rate of 20,000 gallons per year.

Ethanol Summit 2009 is a platform for in-depth discussions on the present and future of biofuels in Brazil and the world, with special focus on ethanol. The event features specialists, researchers, leading business executives and government officials from around the world. Former President Bill Clinton will be a keynote speaker at the event. The summit takes place June 1-3.

To download a photo of Doug Berven, go to http://www.poet.com/news/showRelease.asp?id=168. To see a documentary about POET's pilot cellulosic ethanol plant visit www.poet.com/cellulosedocumentary.htm. Media outlets are welcome to link to the documentary in online coverage. Photos are also available for publication at http://www.poet.com/news/releases.asp.

About POET
POET, the largest ethanol producer in the world, is a leader in biorefining through its efficient, vertically integrated approach to production. The 20-year-old company produces more than 1.54 billion gallons of ethanol annually from 26 production facilities nationwide. POET recently started up a pilot-scale cellulosic ethanol plant, which uses corn cobs as feedstock, and will commercialize the process in 2011. For more information, visit www.poet.com.

CONTACT:
Matt Merritt, Media Relations Specialist
Phone: (605) 965-2225 / (605) 370-9959

###

Read the full story at http://www.prweb.com/releases/POET/Cellulosic_Ethanol/prweb2462974.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Dynamic Outlines Initial Target Markets for Pharmaceutical Cannabinoid Products
2. Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters
3. Intervet/Schering-Plough Animal Health Outlines Strength of the Combination
4. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
5. Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
6. Researchers outline structure of largest nonvirus particle ever crystallized
7. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
8. Solazyme Testing BlueFire Ethanol Cellulosic Sugars in Its Microalgae Renewable Oil Production Process
9. Research Reinforces Economic, Environmental Benefits of Corn Cobs as Source for Cellulosic Ethanol
10. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
11. Verenium Announces First Commercial Cellulosic Ethanol Project
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
POET to Outline Cellulosic Ethanol's Present, Future at Brazil's Ethanol Summit 2009 
(Date:4/26/2017)... HATFIELD, Pa. , April 26, 2017 /PRNewswire/ ... drug delivery platform, has signed a collaborative and ... through Dr. Silvia Muro . The overall ... pharmacokinetics and pharmacodynamics of various 3DNA designs and ... aims involve targeting diseases of the vasculature as ...
(Date:4/25/2017)... PROVIDENCE, R.I. , April 25, 2017 /PRNewswire/ ... EpiVax, Inc. ("EpiVax") has licensed its novel immune-modulating technology ... in autoimmune disease and allergy. Tregitopes, ... discovered in human immunoglobulin by EpiVax CEO ... Martin. Similar to intravenous immunoglobulin G, an autoimmune ...
(Date:4/24/2017)... Linda, Ca (PRWEB) , ... April 24, 2017 ... ... protect proteins from thermal denaturation in a cellular milieu; however, the broad application ... a lack of simple platforms with sensitive quantitative readouts. Cell-based thermal stabilization assays ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... and Webster Bank, today announced first round funding to three startups through the ... early-stage financial support to new business startups affiliated with UConn. , The UConn ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... grow at a CAGR of 30.37% during the period 2017-2021. ... prepared based on an in-depth market analysis with inputs from industry ... over the coming years. The report also includes a discussion of ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):